Radiation Therapy for Arthritis

A low-dose, non-surgical option for relieving chronic joint pain and inflammation in patients with arthritis who have not responded to conventional treatments.
APPOINTMENT
Call Now
Radiation Therapy for Arthritis

Table of Contents

What is radiation therapy for arthritis?

Radiation therapy for arthritis, sometimes called low-dose radiotherapy (LDRT) (or radiosynoviorthesis), uses carefully controlled doses of ionizing radiation to reduce inflammation in affected joints. Unlike the high doses used in cancer treatment, the radiation applied for arthritis is extremely low and targets the synovial tissue, which is the lining of the joint responsible for chronic inflammation and pain.

This approach has been used in Europe for decades and is gaining renewed attention in the United States as research continues to demonstrate its effectiveness for patients with persistent, treatment-resistant joint pain. It is considered when other therapies have provided insufficient relief.

Which types of arthritis can radiation therapy treat?

Low-dose radiation therapy has been studied and applied across several forms of arthritis and related inflammatory joint conditions. Your care team will assess your diagnosis, symptom severity, and prior treatment history to determine whether this approach is appropriate. Conditions commonly treated include:

  • Osteoarthritis affecting the hands, knees, hips, or shoulder joints
  • Rheumatoid arthritis with persistent synovitis in specific joints
  • Psoriatic arthritis with localized joint involvement
  • Ankylosing spondylitis with painful enthesitis at tendon and ligament attachment sites
  • Calcific tendinitis, particularly of the shoulder
  • Heel spurs and plantar fasciitis that have not responded to physical therapy or injections

Who is a good candidate for this treatment?

Radiation therapy for arthritis is typically considered for patients with moderate to severe joint pain that has persisted despite conventional therapies. A multidisciplinary evaluation, often involving your rheumatologist and a radiation oncologist, helps determine whether you are an appropriate candidate. You may be a good candidate if you:

  • Have documented arthritis or inflammatory joint disease confirmed by imaging or clinical evaluation
  • Have not achieved adequate relief from NSAIDs, corticosteroid injections, or physical therapy
  • Are not a suitable candidate for or wish to delay joint replacement surgery
  • Have localized joint symptoms rather than diffuse, whole-body disease activity
  • Are not pregnant and do not have active infection at the treatment site

Patients who are currently managing arthritis with biologic medications or disease-modifying antirheumatic drugs (DMARDs) can often still receive radiation therapy, though your team will coordinate timing and dosing carefully.

What does a treatment session involve?

External beam low-dose radiation therapy for arthritis is non-invasive, painless, and does not require anesthesia or hospitalization. Here is what a typical course looks like:

  1. A simulation appointment is scheduled to map the target joint using imaging, allowing the team to plan the precise radiation field.
  2. Custom positioning aids may be created to ensure consistent, accurate delivery at each visit.
  3. Each treatment fraction takes approximately 10 to 20 minutes from arrival to departure, with the actual radiation delivery lasting only a few minutes.
  4. You lie still on the treatment table while the linear accelerator delivers radiation from several angles to the joint.
  5. You feel nothing during the treatment itself and can drive yourself to and from appointments.
  6. Sessions are typically scheduled three times a week for 2 weeks completing a course of 6 fractions.

What to expect after treatment

Pain relief from low-dose radiation therapy often develops gradually over 6 to 12 weeks following the completion of treatment. Some patients experience a brief, temporary increase in joint discomfort in the first few days after starting therapy, which resolves on its own.

How effective is low-dose radiation therapy for arthritis?

Clinical evidence, particularly from European centers with decades of experience, supports the effectiveness of LDRT for benign painful conditions. Outcomes vary by condition and individual, but published data consistently show:

  • Meaningful pain reduction in 60 to 80 percent of patients with osteoarthritis or heel spurs
  • Sustained relief lasting 12 months or longer in the majority of responders
  • High response rates for calcific tendinitis of the shoulder, often exceeding 70 percent
  • Reduced reliance on pain medications and anti-inflammatory drugs following treatment
  • Improved functional ability and quality of life in patients who respond well

Results are generally better when the affected joint has active inflammation rather than purely structural, end-stage degeneration. Your radiation oncologist will discuss realistic expectations based on your specific diagnosis and imaging findings.

Is low-dose radiation therapy safe?

The doses used for arthritis treatment are far below those associated with radiation-related risks. A full course of LDRT for arthritis delivers a total dose in the range of 3 to 6 Gy (Gray), compared to 50 to 70 Gy typically used in cancer therapy. At these levels, the risk of radiation-induced complications is considered extremely low.

Possible temporary effects

  • Mild skin redness or warmth at the treatment site
  • Temporary increase in joint pain or stiffness in the first week
  • Fatigue, which is usually minimal at low doses
  • Localized swelling that resolves within days

Long-term safety considerations

  • No significant increase in secondary cancer risk at doses used for arthritis
  • Repeat treatments are possible with appropriate intervals between courses
  • Special caution is applied for patients under age 40 due to longer life exposure timeframe
  • Avoided in pregnancy or in patients with certain connective tissue disorders

Your radiation oncologist will review your full medical history, prior radiation exposure, and current medications before recommending a treatment plan.

How does radiation therapy compare to other arthritis treatments?

Radiation therapy is not a first-line treatment but occupies an important role in the broader spectrum of arthritis management. It complements rather than replaces other approaches:

  • Unlike NSAIDs and corticosteroids, radiation therapy does not require ongoing dosing and carries no risk of gastrointestinal or systemic side effects from repeated use
  • Unlike joint replacement surgery, it is non-invasive and carries no surgical or anesthetic risk
  • Unlike biologic medications, it does not suppress the immune system and can be used in patients who cannot tolerate immunosuppression
  • Unlike hyaluronic acid or platelet-rich plasma injections, its effects have been validated in larger clinical series and randomized studies for certain indications

For many patients, LDRT works best as part of an integrated care plan that continues to include physical therapy, appropriate medications, and regular follow-up with a rheumatologist.

Continuing care after treatment

Follow-up after a course of radiation therapy is important for monitoring your response and coordinating ongoing joint care. Your plan will typically include:

  • A follow-up visit with your radiation oncologist at 4 to 12 weeks to assess pain response and document outcomes
  • Continued management with your rheumatologist or primary care physician for disease-modifying therapy if applicable
  • Physical therapy or occupational therapy to optimize joint function as pain decreases

Patients who respond well to an initial course and later experience recurrence of symptoms may be candidates for a repeat treatment series after an appropriate interval, typically at least 12 months.

Schedule an Appointment with Unio Specialty Care Today! Our team is ready to help you find lasting relief. Contact us to get started.

FAQs

Yes. The doses used to treat arthritis are far lower than those used in cancer care — typically 3 to 6 Gy total, compared to 50 to 70 Gy for cancer treatment. At these levels, the risk of radiation-related complications is considered extremely low. There is no significant increase in secondary cancer risk, and most side effects, such as mild skin redness or temporary joint discomfort, are short-lived.
Pain relief typically develops gradually over 6 to 12 weeks following the completion of treatment. Some patients notice improvement sooner, while others may not experience full benefit until several weeks after their last session. For most responders, relief is sustained for 12 months or longer.
Good candidates are patients with moderate to severe joint pain that has not responded adequately to NSAIDs, corticosteroid injections, or physical therapy, and who are not ready for or not suited to joint replacement surgery. The treatment works best when there is active inflammation in a localized joint. A multidisciplinary evaluation with a rheumatologist and radiation oncologist determines eligibility.
A standard course consists of 6 treatment fractions, delivered three times per week over two weeks. Each session takes only 10 to 20 minutes from arrival to departure, with the actual radiation delivery lasting just a few minutes. The treatment is painless, requires no anesthesia, and patients can drive themselves to and from appointments.
No significant increase in cancer risk has been found at the doses used for arthritis treatment. The total radiation dose for a full course of LDRT (3 to 6 Gy) is dramatically lower than doses associated with cancer risk. Special caution is applied for patients under age 40 due to their longer life expectancy, and the treatment is avoided during pregnancy.